patient access before clinical trials

Build Customer Relationships via Expanded Access Programs: A Free Report

Development of specialty therapies is on the rise, especially for rare diseases, fueling an increase in patient awareness and advocacy. More often manufacturers are being asked to implement Expanded Access Programs (EAPs) while products conclude clinical trials. These programs set the tone for the relationship between the brand and the patient, making it critical to design the EAP with a variety of factors in mind. Download our free report that outlines key insights that every manufacturer should know about EAPs

Subscribe to RSS - patient access before clinical trials